Skip to main content
Clinical Trials/DRKS00024992
DRKS00024992
Not yet recruiting
Not Applicable

Prevalence of cardiac impairments after COVID-19

niversitätsklinikum Heidelberg0 sites200 target enrollmentApril 7, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitätsklinikum Heidelberg
Enrollment
200
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 7, 2021
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Heidelberg

Eligibility Criteria

Inclusion Criteria

  • Age of at least 18 years and ability to consent
  • \- COVID\-19 at least 4 months ago \- proven by SARS\-Cov\-2 PCR or antibody test

Exclusion Criteria

  • \- Contraindications to MRI examinations \- especially MRI incompatible implants, clinical instability and severe claustrophobia.
  • \- Heart failure that existed prior to COVID\-19
  • \- Myocardial diseases (heart failure, cardiomyopathies, myocarditis) that existed prior to COVID\-19
  • \- Coronary artery disease, which requires or required coronary intervention and myocardial infarction.
  • \- Prior cardiac surgery (e.g., bypass) and device implantation (e.g., heart valves, PFO occluders)
  • \- Atrial fibrillation that existed prior to COVID\-19
  • \- Active cancer
  • \- Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials